UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 or 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): September 27, 2019

Rennova Health, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

400 S. Australian Avenue, Suite 800, West Palm Beach, Florida 33401

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Item 1.01. Entry into a Material Definitive Agreement.

Rennova Health, Inc. (the “Company”), on September 27, 2019, issued a promissory note (the “Note”) to a lender in the principal amount of $1,900,000. The Company received proceeds of $1,600,000. The first principal payment of $1,000,000 is due on or before November 8, 2019 and the remaining $900,000 is due on or before December 26, 2019. The Note does not bear interest except upon the occurrence of an Event of Default (as defined in the Note). The Note is unsecured and is guaranteed by Christopher Diamantis, a director of the Company.

The foregoing description of the Note does not purport to be complete and is qualified in its entirety by reference to the form of the Note, which is attached hereto as Exhibit 10.176 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.